We are dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve outcomes for women.
Vermillion to Present at the Canaccord Genuity 37th Annual Growth Conference on August 10th
Valerie Palmieri, President and Chief Executive Officer of Vermillion Inc., will provide a corporate overview at the Canaccord Genuity 37th Annual Growth Conference, being held August 9-10 in Boston, Massachusetts.
Date: Thursday, August 10
Time: 1:00pm Eastern Time
Location: InterContinental Boston Hotel, Hong Kong Room
Canaccord Tenuity, Medical Technologies & Diagnostics Forum
November 17, 2016
Westin Grand Central Hotel
New York, New York
AAGL 45th Annual Global Congress
November 14-18, 2016
The Rosen Hotel
Third Quarter 2016 Financial Results and Investor Conference Call
November 10, 2016 at 4:30 p.m. EST
Join by phone:
- Domestic: 1-888-296-4197
- International: 1-719-2462
- Conference ID: 6709878
Join by webcast, here.
Replay dial-in numbers (available through): November 24, 2016
- Domestic: 1-844-512-2921
- International: 1-412-317-6671
- Replay PIN: 6709878
Understanding New Changes to the OVA1 Results Report
November 3, 3016
East Coast: 12:30-12:45 p.m. EST
West Coast: 12:30-12:45 p.m. PST
Presented by: Dr. Marra Francis, Chief Medical Officer of Vermillion and Dr. Herb Fritsche, Lab Director of ASPiRA Labs
Register for East Coast, here.
Register for West Coast, here.